IDPH Reports 2 Illinois Counties at an Elevated Community Level for COVID-19
IDPH has recorded a total of 4,127,625 cases and 36,735 deaths, in 102 counties in Illinois since the beginning of the pandemic. The department is reporting 5,278 new confirmed and probable cases of COVID-19 in Illinois in the week ending April 9, and 9 deaths.
"The FDA and CDC's decision to approve a second COVID-19 booster this week demonstrates the real risk that this illness continues to pose for specific groups," said IDPH Director Dr. Sameer Vohra. "Although Illinois overall continues to have low COVID-19 community levels, the virus is still circulating and causing hospitalizations. Vaccines remain the best tool to prevent serious illness. I encourage those individuals who are over 65 or immunocompromised to speak with their health care provider about the benefits of this additional COVID-19 booster."
"Every dose of the vaccine provides a shot of protection against the virus that has taken so much from us over the last few years," said IDoA Director Paula Basta. "If you are eligible for a second updated bivalent booster, strongly consider scheduling it now to keep yourself and your loved ones as protected as possible."
On April 19, the CDC recommended a second bivalent booster for those who are 65 and older if it has been at least four months since their first bivalent booster. For those who are immunocompromised, they are eligible for a second bivalent booster if it has been at least two months since their first bivalent booster.
IDPH is helping Illinoisans stay prepared for any future surge of COVID-19 cases by offering 1 million free COVID-19 rapid antigen tests to Illinois residents in all zip codes outside the City of Chicago through a partnership with the Rockefeller Foundation's public charity, RF Catalytic Capital and its Project ACT (Access COVID Tests) program.
Free or low cost COVID-19 testing locations are also available throughout the state, including in Chicago, and can be found on the IDPH website's testing locator page.
The CDC previously authorized two new bivalent booster vaccines on September 1 that include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an added mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.
Initially, the Moderna COVID-19 Vaccine, Bivalent, was recommended for use as a single booster dose in individuals 18 years of age and older and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 12 years of age and older. On October 12, the CDC authorized the updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through 11 years, and from Moderna for children and adolescents ages 6 through 17 years.
On December 9, the CDC expanded its authorization for bivalent boosters to include children aged 6 months to 5 years. On March 14, the FDA expanded its authorization for bivalent boosters to include children aged 6 months to 4 years who had previously completed their entire Pfizer primary series with the monovalent vaccine. For young children, multiple doses of bivalent vaccine continue to be recommended and will vary by age, vaccine, and which vaccines were previously received.
Under the new recommendations, children 6 months through 5 years of age who are unvaccinated may receive a two-dose series of the Moderna bivalent vaccine (6 months through 5 years of age) OR a three-dose series of the Pfizer-BioNTech bivalent vaccine (6 months through 4 years of age). Children who are 5 years of age may receive two doses of the Moderna bivalent vaccine or a single dose of the Pfizer-BioNTech bivalent vaccine.
Children 6 months through 5 years of age who have received one, two or three doses of a monovalent COVID-19 vaccine may receive a bivalent vaccine, but the number of doses that they receive will depend on the vaccine and their vaccination history.
As of last night, 558 individuals in Illinois were reported to be in the hospital with COVID-19. Of those, 65 patients were in the ICU and 22 patients with COVID-19 were on ventilators. The preliminary seven-day statewide case rate is 44 COVID-19 cases per 100,000 Illinoisans.
In counties at the Medium Community Level, persons who are elderly or immunocompromised (at risk of severe outcomes) are advised to wear a mask in indoor public places. They should also get up to date on COVID-19 vaccines or get their bivalent booster, if eligible.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.